News | Breast Density | February 19, 2019 | Jeff Zagoudis, Associate Editor

Congress Directs FDA to Establish Federal Breast Density Inform Standard

Agency will develop reporting language for minimum amount of information to be provided about a patient’s individual fibroglandular density and associated breast cancer risk

Congress Directs FDA to Establish Federal Breast Density Inform Standard

February 19, 2019 — As part of a federal spending bill passed late Friday, Congress directed the U.S. Food and Drug Administration (FDA) to establish a national minimum standard for including fibroglandular breast density information on mammography reports. While 36 states have already enacted their own breast density inform legislation, the federal version will ensure that every state takes a minimum level of action on making patients aware of the increased breast cancer risk associated with dense breasts.

The law directs the FDA, through the regulatory process, to develop language for reports and summaries from mammography facilities to include with appropriate information about breast density for patients and their providers. According to DenseBreast-info.org, the information must include, at a minimum:

  • The effect of breast density in masking the presence of breast cancer on a mammogram;
  • The qualitative assessment of the patient’s fibroglandular breast density by the provider who interprets the mammogram according to the American College of Radiology Breast Imaging-Reporting and Data System (BI-RADS); and
  • A reminder to patients that individuals with dense breast tissue should talk with their providers if they have any questions or concerns about their summary.

“As part of the funding bill Congress passed yesterday, the FDA must now ensure mammography reports include appropriate breast density information. Dense tissue can hide cancer on mammograms, so this information is vital to catching breast cancer early,” said Sen. Dianne Feinstein (D-Calif)., a longtime supporter of the breast density inform movement who championed the inclusion of the density standard in the current spending bill in the Senate. Rep. Rosa DeLauro (D-Conn.) led efforts in the House.

The grassroots movement to spread information about breast density began in 2009 when Connecticut became the first state to enact a breast density inform law. Those efforts were spearheaded by Nancy Cappello, Ph.D., who was diagnosed with stage 3C breast cancer in February 2004, just six weeks after her annual mammogram came up normal. Her doctor told her the cancer was missed on the mammogram because she had dense fibroglandular breast tissue, a concept that was little-known among patients at the time. Cappello passed away in November from secondary myelodyspastic syndrome (MDS), a bone marrow cancer that was a complication of her prior aggressive breast cancer treatments.

Watch the VIDEO: The Impact of Breast Density Technology and Legislation, an interview with Cappello at RSNA 2017.

Today, 10 years later, the movement has expanded to 36 states, covering an estimated 89 percent of women in the U.S. Each state law has slightly different requirements, however, for how much information is given to patients and providers. According to JoAnn Pushkin, executive director of DenseBreast-info.org, some laws only require that women are informed about breast density generally and not their own density and associated cancer risk.

“Implementation of this national law will help to address this disparity, as all imaging facilities that perform mammography screening will be required to provide at least the level of information required by the FDA’s new reporting requirement,” said Pushkin. Feinstein, DeLauro and others have previously introduced bills in Congress for a national breast density standard that ultimately stalled.

“This law is an important step forward, advanced by the efforts of many advocates, including those of the late Dr. Nancy Cappello of Are You Dense?. We are all grateful for the dedication and resolve of Sen. Dianne Feinstein and Rep. Rosa DeLauro who have championed patient notification in the several past congresses,” said Pushkin.

For more information: www.densebreast-info.org

Related Breast Density Content

Survey Shows Dense Breast Reporting Laws Increase Breast Density Awareness

Fake News: Having Dense Breast Tissue is No Big Deal

VIDEO: Breast Imaging and Risk Assessment at Northwestern Medicine Central DuPage

 

Related Content

Warm Springs Health & Wellness Center Implements Digisonics Solution for OB Ultrasound
News | Ultrasound Women's Health | June 17, 2019
Warm Springs Health & Wellness Center in Warm Springs, Ore., has selected the Digisonics OB PACS (picture archiving...
Fujifilm Announces Nationwide Breast Health Campaign With Mobile Mammography Coach

At the center of the campaign, Fujifilm will be traveling around the U.S. with its "Aspire to Be Fearless" mobile mammography coach to provide educational opportunities for clinicians, raise awareness about the importance of screening and will be providing mammograms to the underserved population in key locations.

News | Mammography | June 14, 2019
Fujifilm Medical Systems U.S.A. Inc. announced a nationwide awareness campaign titled ‘Aspire to Be Fearless’ focused...
Ikonopedia Showcases Risk Assessment and Resolution Manager Tools at SIIM and AHRA
News | Mammography Reporting Software | June 13, 2019
Ikonopedia will showcase its suite of structured breast reporting and Mammography Quality Standards Act (MQSA)...
iCAD Introduces ProFound AI for 2D Mammography in Europe
News | Artificial Intelligence | June 13, 2019
iCAD Inc. announced the launch of ProFound AI for 2D Mammography in Europe. This software is the latest addition to...
Three Palm Software Releases WorkstationOne Version 1.8.8
Technology | Mammography Reporting Software | June 12, 2019
Three Palm Software announced the release of the 1.8.8 version of its breast imaging workstation, WorkstationOne. This...
Volpara Health Technologies to Acquire MRS Systems Inc.
News | Mammography Reporting Software | June 04, 2019
Volpara Health Technologies, Volpara Solutions' parent company, has signed a binding agreement to acquire U.S.-based...
62-year-old female patient presenting for 3D screening mammogram. Location of an indeterminate low-density circumscribed mass was not clearly determined as at the skin line or just under the surface.

62-year-old female patient presenting for 3D screening mammogram. Location of an indeterminate low-density circumscribed mass was not clearly determined as at the skin line or just under the surface.

Feature | Mammography | May 31, 2019 | By Olive Peart M.S., R.T.(R)(M)
In recent years there has been a lot of debate about the role of the...
Quantitative Transmission Ultrasound Featured at Acoustical Society of America

Fused QT Ultrasound 3-D quantitative transmission ultrasound and compounded reflection axial images showing high resolution image of internal organs, tissue, skin and hair of neo-natal piglet. Anatomy courtesy of C. Ruoff, DVM.

News | Ultrasound Imaging | May 29, 2019
May 29, 2019 — QT Ultrasound recently showcased its advanced...
VolparaDensity With Tyrer-Cuzick Model Improves Breast Cancer Risk Stratification
News | Breast Density | May 22, 2019
Research has demonstrated use of Volpara Solutions' VolparaDensity software in combination with the Tyrer-Cuzick Breast...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...